Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Total Inventories : ¥83.4 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Total Inventories?

Zhejiang Shapuaisi Pharmaceutical Co's total inventories for the quarter that ended in Sep. 2024 was ¥83.4 Mil. Zhejiang Shapuaisi Pharmaceutical Co's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Sep. 2024 was ¥84.9 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zhejiang Shapuaisi Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was ¥-0.44.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory for the three months ended in Sep. 2024 was 120.21.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zhejiang Shapuaisi Pharmaceutical Co's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.76.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zhejiang Shapuaisi Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.69.

Zhejiang Shapuaisi Pharmaceutical Co Total Inventories Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Total Inventories Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

86.33

56.54

60.82

59.10

84.32

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Inventories	Get a 7-Day Free Trial															92.49	84.32	78.82	86.29	83.42

Zhejiang Shapuaisi Pharmaceutical Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Zhejiang Shapuaisi Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is

	Net-Net Working Capital Per Share (Q: Sep. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(198.96	+	0.75 * 38.065	+	0.5 * 83.417	-	431.28
-	0	-	2.052)	/	375.925
=	-0.44

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zhejiang Shapuaisi Pharmaceutical Co's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2024 )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
	=	84.8515	/	64.409	*	365 / 4
	=	120.21

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zhejiang Shapuaisi Pharmaceutical Co's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2024 )	/	Average Total Inventories (Q: Sep. 2024 )
	=	64.409	/	84.8515
	=	0.76

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zhejiang Shapuaisi Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	84.8515	/	122.55
	=	0.69

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Zhejiang Shapuaisi Pharmaceutical Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200

Website

https://www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.

Executives

Huang Ming Xiong	Directors, senior managers
Wu Jian Guo	Director
Xu Hong Sheng	senior management
Hu Zheng Guo	Director
Ge Sheng Fang	Director
Feng Xiao	Supervisors
Chen De Kang	Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines